AvePoint (AVPT) Research & Development (2020 - 2026)

AvePoint has disclosed Research & Development across 7 years of filings, most recently posting $13.8 million for Q1 2026.

• In Q1 2026, Research & Development rose 8.44% year-over-year to $13.8 million; the TTM figure through Mar 2026 stood at $53.7 million (up 5.41% YoY), while the FY2025 annual figure was $52.6 million, up 7.98% from the prior year.
• Research & Development advanced to $13.8 million in Q1 2026, from $13.0 million in the prior quarter.
• Over the last five years, Research & Development for AVPT reached as high as $13.9 million in Q3 2025 and fell as low as $6.6 million in Q1 2022.
• The 5-year median for Research & Development is $10.5 million (2024), against an average of $10.7 million.
• The widest YoY moves for Research & Development: up 108.11% in 2022, down 53.1% in 2022.
• A 5-year view of Research & Development shows it stood at $7.5 million in 2022, then grew by 25.3% to $9.4 million in 2023, then soared by 36.81% to $12.9 million in 2024, then advanced by 0.99% to $13.0 million in 2025, then increased by 5.85% to $13.8 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $13.8 million, $13.0 million, and $13.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.